Aims and objectives: To investigate the clinical benefits of using humidification in low-flow oxygen therapy. Specific objectives were to investigate via an assessment of the number of nasal lavages whether humidification can help to decrease the nasal mucus viscosity, to determine whether it can relieve feeding difficulties by comparing the weight gain in infants, to ascertain whether it can relieve respiratory distress by assessing the heart and respiratory rates and contribute to improved clinical outcomes, measured by the length of stay and oxygen requirements.
| INTRODUCTION
Bronchiolitis is the most common lower respiratory infection in infants younger than 2 years of age, and it is mainly caused by the respiratory syncytial virus, RSV. The normal epidemic season for bronchiolitis lasts from December-March, and the pathology includes acute inflammation, bronchiole oedema and increased mucus production. The signs and symptoms begin with rhinitis and cough, which may progress to tachypnoea, wheezing, rales, use of accessory muscles and/or nasal flaring (American Academy of Pediatrics, 2014) .
The maintenance of hydration and oxygenation, as a supportive treatment, is generally recommended to manage acute bronchiolitis, as different trials of other treatments such as corticosteroids or antibiotics have not demonstrated conclusive benefits (American Academy of Pediatrics, 2014; Krilov, 2011) .
| Background
With regard to oxygenation management, noninvasive ventilation is commonly implemented during hospitalisation, in the form of either high-flow (HF) oxygen therapy or low-flow (LF) oxygen therapy.
When the HF system is implemented, the humidification of oxygen is a usual clinical practice, undertaken to prevent some complications of dry oxygen delivery, including nasal dryness and discomfort (Cuquemelle et al., 2012) . However, despite the complications of the dry oxygen conditioning, there is neither a widespread consensus nor any standard recommendations about the use of humidified oxygen in LF rates.
On the one hand, some hospital guidelines always recommend the humidification of oxygen in infants, regardless of the flow rates, as the Saskatoon Health Region Nursing Practice Committee policies (2006) . On the other hand, Nath, Ponnusany, Willis, Bisset, and Clarke (2010) reported a wide variety of clinical practices in the neonatal care with regard to humidification measures in LF therapy, thus complicating any effort to define standard policies, as stated above. Lastly, Umoren, Odey, and Meremikwu (2011) concluded that there have not been enough well-designed trials to examine the benefits of humidified oxygen in the treatment of acute bronchiolitis in children of up to 3 years of age. Because of this lack of evidence and consensus, both Nath et al. (2010) and Umoren et al. (2011) recommend further research to explore the effectiveness of humidified vs. nonhumidified oxygen therapy. In addition, the humidification may be helpful to prevent the thickening of secretions (Walsh & Smallwood, 2017) and relieving the main symptoms of respiratory distress. Finally, no adverse effects have been reported, either with steam humidification (Umoren et al., 2011) , or using prefilled bubble humidifiers (Yamashita, Nishiyama, Yokoyama, Abe, & Manabe, 2005) , and only benefits may be expected.
Thus, given this call for an examination of the benefits of humidified oxygen in low-flow therapy, the humidification of oxygen in LF was implemented as a general practice in the management of all infants with bronchiolitis in our paediatric ward, and we compared its effects to nonhumidified oxygen therapy. The overall objective was to investigate the clinical benefits of using humidification as a usual clinical practice in low-flow oxygen therapy in the management of infants with acute bronchiolitis. Our specific hypotheses were that the use of the humidification in low-flow oxygen therapy in infants with mildmoderate bronchiolitis would reduce their nasal mucus viscosity, thus alleviating the infants' feeding difficulties and easing their respiratory distress, and that it would improve their clinical outcomes.
2 | METHODOLOGY 2.1 | Design, setting and participants A quasi-experimental study with a nonconcurrent control group was conducted at our general paediatric ward, in a Spanish nontertiary hospital. A total of 97 infants with mild-moderate bronchiolitis with low-flow oxygen therapy, defined as ≤2 L/min, administered via nasal cannula, were enrolled. The control (nonhumidified) group data were gathered during the annual RSV incidence peak from Novem- We included all infants younger than 6 months old, with diagnoses of bronchiolitis based on an initial episode of respiratory distress, with LF oxygen therapy and bronchodilators (salbutamol and/ or epinephrine), nebulised with hypertonic saline 3%. We excluded infants with previous respiratory tract infections and co-infections at admission (pneumonia, bordetella pertussis, tract urinary infection), and infants with risk factors for severe disease, such as chronic diseases (congenital heart disease, chronic lung disease, immunodeficiency, neuromuscular diseases) and premature birth (American Academy of Pediatrics, 2014; Krilov, 2011) . Those infants who needed different management due to co-infections detected during the bronchiolitis treatment, as well as those who ultimately needed to be admitted in the paediatric intensive care unit (PICU), were also excluded ( Figure 1 ).
What does this paper contribute to the wider global clinical community?
• There are no prior recommendations nor any conclusive results related to the clinical benefits of humidification in low-flow oxygen therapy in infants.
• Our findings support the use of humidification in the management of mild-to-moderate bronchiolitis as a usual clinical practice to improve the clinical outcomes and comfort of infants.
| Study variables
To evaluate the degree to which humidification can contribute to a decrease in nasal mucus viscosity, the number of nasal lavages needed to alleviate the nasal obstruction was recorded as an indirect indicator. To assess feeding difficulties, data were gathered on the infants' weight gain, with each infant's weight in grams recorded at admission and at discharge, in each case with the baby naked and weighed on the same digital scale both times. To evaluate respiratory distress, measurements were taken of the infants' respiratory rate (RR) (counted by professionals during 1 min) and of their heart rate (HR) and oxygen saturation (SpO2) (measured with pulse oximetry) at admission and then after 24, 48 and 72 hr, and again at discharge. The distress score was also recorded at admission using the Sant Joan de D eu Bronchiolitis Score (BROSJOD) (Balaguer et al., 2017) . The bronchodilator therapy was recorded, because the use of epinephrine rather than salbutamol may be slightly more effective (Modaressi, Asadian, & Faghihinia, 2012) . To assess the length of stay (LoS), we defined the period of days between the admission in our ward and the validation of the discharge criteria, generally when the oral fluid intake was adequate, the SpO2 was >95% without oxygen supply for at least 24 hr, and the infant exhibited minimal wheezes, rales and chest retractions. To measure the length of oxygen requirement (LOR), we recorded the period of days necessary to decrease the work of breathing to the minimum with the supply of oxygen. 
| Potential confounders

| Procedure
The choices of management practices for infants with bronchiolitis at our hospital always depend on each infant's clinical status. These interventions range from the maintenance of oxygenation through the use of LF when the bronchiolitis episode is mild or moderate and the SpO2 < 94%, to the maintenance of hydration by encouraging the oral fluid intake in infants diagnosed with a mild-moderate episode, and to the prescription of intravenous fluids or tube feeding, only in very exceptional and critical situations. They also include the administration of bronchodilators by nebulising salbutamol and/or epinephrine with 3% hypertonic saline and antibiotic therapy. In addition, the nasal lavages are also recommended to alleviate the nasal obstruction due to mucus viscosity. This practice consists of the instillation of 2-5 cc of normal saline into the infant's nostrils, a process that is much less aggressive than nasal suctioning, although it still causes discomfort.
Thus, to reduce the discomfort of infants associated to nasal lavages, we implemented the humidification in infants with bronchiolitis and LF oxygen therapy using the bubble sterile device Respiflo©, Tyco | 1127
were excluded from the study, as mentioned above (Figure 1 ).
Because this practice was implemented as a usual prescription, a concurrent group without humidification was not possible.
| Data collection
Data from the control, nonhumidified group (2010-2012) were collected via a review of medical records, and data from the humidified group (2012-2014) were gathered using a specific form, designed for the purposes of this study. Demographic data from both groups were also recorded. 
| Sant Joan de D eu Bronchiolitis Score (BROSJOD)
The Sant Joan de D eu Bronchiolitis Score (BROSJOD score) was originally developed in 1999 (Balaguer et al., 2017) , and it was recently validated as a diagnostic severity tool in infants aged less than 2 years, mean age 52.5 days, admitted to Hospital Sant Joan de D eu with acute bronchiolitis (Emergency Department, ward, or PICU) (Balaguer et al., 2017 Table 2 shows the infants' clinical and demographic characteristics.
Our groups were comparable in age, admission weight, BROSJOD scores, RSV diagnoses, antibiotic therapy, radiography findings and family smoking habits. However, the groups showed differences in terms of feeding and bronchodilator treatment, so these variables were adjusted in the statistical analysis, in regression models. Concerning the group characteristics, 71% of infants in the control group (nonhumidified) and 83% in the humidified group were diagnosed as RSV positive, while most subjects had mild-to-moderate bronchiolitis scores, were of less than ninety days of age and had been exclusively breastfed. Table 3 shows the descriptive statistics and the results of the bivariate comparisons for each study variable.
| Effects of humidification
To analyse the effect of humidification on the number of nasal lavages, a Poisson regression model was tested. This model included the interaction of humidification with the BROSJOD score adjusting for breastfeeding and age. Table 4 shows the results of the final model, where only the interaction of humidification with the BROS-JOD score was kept. The humidified group showed a significant reduction in the number of nasal lavages. As the score decreases, the number of nasal lavages is also reduced, with some cases showing a reduction by as much as 78.5% (Score BROSJOD = 3).
Concerning feeding difficulties, the infants' weight gain during the stay was analysed using a linear regression model adjusted for age, but no significant differences were found (B = À2.456 g [95% CI: À64.5 to 59.6], p = 0.938).
To analyse the effect of humidification on respiratory distress, linear regression models were tested, with the HR and RR as response variables. This model included the interaction of humidification with the BROSJOD score and adjusted for bronchodilators and age. Table 5 To analyse the effect of humidification on clinical outcomes, Poisson regression models were applied, with LoS and LOR as response variables. These models also included the interaction of humidification with the BROSJOD score and were adjusted for admission weight, breastfeeding and age. Table 6 shows the final model, where only the interaction of humidification with the BROS-JOD score was kept. As this score decreases, there is a corresponding reduction in the LoS and LOR, with the values for the latter two variables decreasing by as much as 58.2% and 69.5%, respectively (BROSJOD score = 3).
| DISCUSSION
Bronchiolitis is an active area of research. Ninety per cent of infants are infected with RSV in the first 2 years of life, and the treatment of this virus comes with a huge healthcare cost (American Academy of Pediatrics, 2014). For this reason, numerous reviews are constantly being conducted to improve the management of these infants (Øymar, Skjerven, & Mikalsen, 2014; Schroeder & Mansbach, 2014; Zentz, 2011) . In this sense, the use of humidification in HF rates is almost an unquestionable clinical practice that helps to enhance infants' comfort levels (Cuquemelle et al., 2012) and reduce the risk of complications (Dysart, Miller, Wolfson, & Shaffer, 2009 ). However, as mentioned previously, there are discrepancies in the research on the use of humidification in LF, because to date, there is no conclusive evidence of its benefits (Nath et al., 2010; Umoren et al., 2011) . To our knowledge, this is the first study reporting clinical benefits of the use of humidification in LF oxygen therapy in mild-moderate bronchiolitis.
| Number of nasal lavages
Humidification seems to be helpful in reducing the number of nasal lavages needed to alleviate the nasal obstruction. The data confirm our hypothesis, as the humidification in LF may lighten secretions, as 
| Feeding difficulties
The difference in weight gain was not statistically significant. These results, however, could have been significantly different if we had measured and analysed their weight daily to examine the fluctuations. In addition, we could have examined how well the infant was feeding (i.e., how long it takes to complete a feed, and if the infant is breastfeeding, enquire as to whether the mother feels that her breast is being emptied), as Fitzgerald and Kilham (2004) recommended as ways to assess the clinical severity of bronchiolitis episodes.
| Respiratory distress
Humidification decreased the mean HR significantly, and no statistical differences in the RR were found. These findings partially confirm our hypothesis, as decreasing the thickness of secretions may relieve respiratory distress, as was pointed out by Umoren et al. (2011) . HR is considered a distress indicator in some instruments assessing bronchiolitis severity, including the BROSJOD score and other generally accepted measures like the Wood-Downes Clinical Scoring System, modified by Ferr es (Flores-Gonz alez et al., 2016) . When these instruments are used, lower HR generally contributes to lower scores and thus to decreased severity and improvements in infants' Pearson Chi-squared test to compare groups. Sample (n), p-values (P), respiratory syncytial virus (RSV), Bronchiolitis Score Sant Joan de Déu (BROSJD). Data are missing on smoking pregnant (n = 10. 10.3%), smoking household (n = 19, 19.6%) and radiography findings (n = 4, 4.1%). Sample (n), mean (M), standard deviation (SD), median (Md), interquartile range (IQR), heart rate (HR), respiratory rate (RR), beats per minute (bpm), respirations per minute (rpm).
T A B L E 2 Demographic and clinical characteristics of infants
Nonhumidified (n = 49) Humidified (n = 48) p % (n) % ( n)
T A B L E 3 Descriptive statistics of study variables
No humidified Humidified
clinical evolution. The RR slightly decreased, but results were statistically not significant. This fact may be due to the measuring system used, because whereas the HR was measured with a pulse oximeter, which brings valid and reliable data, RR was measured by professionals, who gathered this data by counting. In this sense, the recording of RR may vary from one professional to another, and so the analysis may be altered. So, no conclusive results were found concerning RR, but our results regarding the reduction in HR were statistically significant and may be helpful for future research. ExpB (95% CI) (ExpB -1) * 100 p
Humidification (yes)
Score 3 (n = 4) 0.341 (0.215 to 0.539) À65.9% (À78.5% to À46.1%) <.001
Score 4 (n = 11) 0.406 (0.286 to 0.577) À59.4% (À71.4% to À42.3%) <.001
Score 5 (n = 18) 0.485 (0.375 to 0.627) À55.1% (À62.5% to À37.3%) <.001
Score 6 (n = 24) 0.579 (0.473 to 0.708) À42.1% (À52.7% to À29.2%) <.001
Score 7 (n = 19) 0.691 (0.557 to 0.855) À30.9% (À44.3% to À14.5%) <.001
Score 8 (n = 13) 0.824 (0.619 to 1.09) À17.6% (À38.1% to 9.8%) .186
Poisson regression coefficients (Exp. (B)), 95% confidence intervals (95% CI), sample (n).
(ExpB -1) * 100 shows the effect of humidification on the number of nasal lavages expressed in percentage of change. The initial model included the interaction of humidification with Score BROSJOD, and age and breastfeeding as potentials confounders, but only the interaction with Score BROSJOD was kept in the final model. Poisson regression coefficients (Exp(B)), 95% confidence intervals (95% CI). LoS and LOR in days.
(ExpB -1) * 100 shows the effect of humidification on length of stay and length of oxygen requirement expressed in percentage of change. The initial model included the interaction of humidification with Score BROSJOD, and admission weight, breastfeeding and age as potential confounders, but only the interaction with Score was kept in the final model.
humidification with the BROSJOD score, no other associations were found, although we initially expected an association between LoS and breastfeeding. The lack of association between these two variables could be explained by the fact that most of the infants in our groups were of less than ninety days of age, whereas the contribution of exclusive breastfeeding to improve outcomes in respiratory tract infections, including reductions in the LoS, has been described for infants who have been exclusively breastfed for at least 4 months (American Academy of Pediatrics, 2014; Duijts et al., 2010) .
| Limitations
Some limitations should be noted and taken into account for further research. Our design did not include a concurrent control group without humidification, because this system was implemented as a general practice at our ward. While this nonexperimental design does not ensure the comparability between groups, differences detected between groups regarding potential confounders were controlled for using regression models, as mentioned in the results section. We did not have a control group without bronchodilator treatment because our clinicians administer bronchodilators as a general rule, as detailed in the procedure section. We recorded the clinical distress score at admission to determine the severity of the bronchiolitis episode, but we did not register the score evolution during the stay. We did not quantitatively register the oral fluid intake of infants during the study, so we could not control for their hydration status as would have been desirable. Finally, we could not analyse the interaction of humidification with BROSJOD scores over 8, due to the insufficient number of infants in the humidified group. and guidelines have highlighted the relevance of suctioning nasal secretions before any inhaled therapy application or prior to feeding (Black & Brennan, 2011; Bronchiolitis Guideline Team, Cincinnati Children's Hospital Medical Center, 2005) . In these cases, we usually do nasal lavages, which are much less aggressive than nasal suctioning.
Moreover, some other issues concerning the economic costs should also be highlighted. Regarding the humidification system implementation, the bubble device in our public hospital costs less than one euro per infant/week, whereas a 1-day stay costs nearly 300 euros. Although the costs may vary depending on the device brand used and the clinical scenario, the humidification system still remains economical (Villanueva & Bay on, 2013) . Additionally, other cost savings should be taken into account if the humidification in LF is implemented, including the cost-time of the nursing procedures and the medical costs resulting from the possible complications of dry oxygen delivery. In this sense, further research is needed, because in this study, we did undertake an analysis of the costeffectiveness of humidification in LF. We also recommend conducting prospective studies with a control group to clarify the role of bronchodilators in association with the humidification, registering the exact dose frequency of epinephrine and salbutamol. Finally, to follow infants' clinical evolution more accurately, we strongly recommend registering distress scores daily, because this measure seems to be a good predictor of clinical outcomes, as highlighted by Balaguer et al. (2017) .
| CONCLUSION
The use of humidification in LF oxygen therapy seems to be clinically beneficial. Humidifying the nasal and oral mucosa can help to lighten secretions, reduce the number of nasal lavages and minimise infants' discomfort associated with mucosa dryness, nasal obstruction and professional procedures. Humidification also relieves respiratory distress and reduces the LoS and the LOR. Our findings support the use of humidification in LF as a regular clinical practice in the management of mild-moderate bronchiolitis.
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